The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.
about
Novel RNA chaperone domain of RNA-binding protein La is regulated by AKT phosphorylationAutoradiography imaging in targeted alpha therapy with Timepix detectorLARP1 post-transcriptionally regulates mTOR and contributes to cancer progression90Y-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer XenograftsImage-derived biomarkers and multimodal imaging strategies for lung cancer management.
P2860
The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The La antigen is over-express ...... La-specific antibody APOMAB®.
@en
The La antigen is over-express ...... La-specific antibody APOMAB®.
@nl
type
label
The La antigen is over-express ...... La-specific antibody APOMAB®.
@en
The La antigen is over-express ...... La-specific antibody APOMAB®.
@nl
prefLabel
The La antigen is over-express ...... La-specific antibody APOMAB®.
@en
The La antigen is over-express ...... La-specific antibody APOMAB®.
@nl
P2093
P2860
P50
P356
P1433
P1476
The La antigen is over-express ...... La-specific antibody APOMAB®.
@en
P2093
Alexander H Staudacher
Andrew Ruszkiewicz
Cara K Fraser
Jim Manavis
P2860
P2888
P356
10.1186/2191-219X-4-2
P577
2014-01-04T00:00:00Z
P5875
P6179
1051290883